Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Jul, 2014 | Pages:
52 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Nerviano Medical Sciences - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Nerviano Medical Sciences - Product Pipeline Review - 2014', provides an overview of the Nerviano Medical Sciences 's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Nerviano Medical Sciences 's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Nerviano Medical Sciences including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Nerviano Medical Sciences 's human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Nerviano Medical Sciences 's pipeline products Reasons to buy - Evaluate Nerviano Medical Sciences 's strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Nerviano Medical Sciences in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Nerviano Medical Sciences 's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Nerviano Medical Sciences and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Nerviano Medical Sciences - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Nerviano Medical Sciences and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 5 List of Figures 5 Nerviano Medical Sciences Snapshot 6 Nerviano Medical Sciences Overview 6 Key Information 6 Key Facts 6 Nerviano Medical Sciences - Research and Development Overview 7 Key Therapeutic Areas 7 Nerviano Medical Sciences - Pipeline Review 10 Pipeline Products by Stage of Development 10 Pipeline Products - Monotherapy 11 Pipeline Products - Out-Licensed Products 12 Out-Licensed Products/Combination Treatment Modalities 13 Nerviano Medical Sciences - Pipeline Products Glance 14 Nerviano Medical Sciences - Clinical Stage Pipeline Products 14 Phase II Products/Combination Treatment Modalities 14 Phase I Products/Combination Treatment Modalities 15 Nerviano Medical Sciences - Early Stage Pipeline Products 16 Preclinical Products/Combination Treatment Modalities 16 Discovery Products/Combination Treatment Modalities 17 Nerviano Medical Sciences - Drug Profiles 18 danusertib 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 milciclib 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 nemorubicin 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 NMS-E628 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 NMS-1116354 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 NMS-1286937 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 NMS-616 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 NMS-P118 27 Product Description 27 Mechanism of Action 27 R&D Progress 27 NMS-P153 28 Product Description 28 Mechanism of Action 28 R&D Progress 28 NMS-P285 29 Product Description 29 Mechanism of Action 29 R&D Progress 29 NMS-P506 30 Product Description 30 Mechanism of Action 30 R&D Progress 30 NMS-P626 31 Product Description 31 Mechanism of Action 31 R&D Progress 31 NMS-P648 32 Product Description 32 Mechanism of Action 32 R&D Progress 32 NMS-P715 33 Product Description 33 Mechanism of Action 33 R&D Progress 33 NMS-P914 34 Product Description 34 Mechanism of Action 34 R&D Progress 34 NMS-P948 35 Product Description 35 Mechanism of Action 35 R&D Progress 35 NMSE-973 36 Product Description 36 Mechanism of Action 36 R&D Progress 36 PHA-793887 37 Product Description 37 Mechanism of Action 37 R&D Progress 37 Small Molecule to Inhibit RET for Oncology 38 Product Description 38 Mechanism of Action 38 R&D Progress 38 NMS-873 39 Product Description 39 Mechanism of Action 39 R&D Progress 39 Small Molecule to Inhibit Pim Kinase for Oncology 40 Product Description 40 Mechanism of Action 40 R&D Progress 40 Nerviano Medical Sciences - Pipeline Analysis 41 Nerviano Medical Sciences - Pipeline Products by Target 41 Nerviano Medical Sciences - Pipeline Products by Route of Administration 43 Nerviano Medical Sciences - Pipeline Products by Molecule Type 44 Nerviano Medical Sciences - Pipeline Products by Mechanism of Action 45 Nerviano Medical Sciences - Recent Pipeline Updates 47 Nerviano Medical Sciences - Dormant Projects 49 Nerviano Medical Sciences - Locations And Subsidiaries 50 Head Office 50 Appendix 51 Methodology 51 Coverage 51 Secondary Research 51 Primary Research 51 Expert Panel Validation 51 Contact Us 52 Disclaimer 52
List of Tables Nerviano Medical Sciences, Key Information 6 Nerviano Medical Sciences, Key Facts 6 Nerviano Medical Sciences - Pipeline by Indication, 2014 8 Nerviano Medical Sciences - Pipeline by Stage of Development, 2014 10 Nerviano Medical Sciences - Monotherapy Products in Pipeline, 2014 11 Nerviano Medical Sciences - Out-Licensed Products in Pipeline, 2014 12 Nerviano Medical Sciences - Out-Licensed Products/ Combination Treatment Modalities, 2014 13 Nerviano Medical Sciences - Phase II, 2014 14 Nerviano Medical Sciences - Phase I, 2014 15 Nerviano Medical Sciences - Preclinical, 2014 16 Nerviano Medical Sciences - Discovery, 2014 17 Nerviano Medical Sciences - Pipeline by Target, 2014 42 Nerviano Medical Sciences - Pipeline by Route of Administration, 2014 43 Nerviano Medical Sciences - Pipeline by Molecule Type, 2014 44 Nerviano Medical Sciences - Pipeline Products by Mechanism of Action, 2014 46 Nerviano Medical Sciences - Recent Pipeline Updates, 2014 47 Nerviano Medical Sciences - Dormant Developmental Projects,2014 49
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
